sur SWK Holdings Corp.
SWK Holdings Highlights Recent Achievements and Provides Portfolio Update
SWK Holdings Corporation (NASDAQ:SWKH), a specialty finance company focused on life sciences, announced several corporate and borrower portfolio achievements. The company advanced capital to two existing borrowers during Q2 2024 and is planning an additional closing soon. New CFO Adam Rice joined in July, and Courtney Baker was promoted to Controller in June. SWK repurchased $1 million of stock during Q2 and a total of $3.4 million year-to-date.
New financings included $2 million to AOTI, Inc. in May and $5 million to Journey Medical Corporation in June. Noteworthy portfolio updates: AOTI raised £35.1 million through an IPO on the London Stock Exchange, Biolase broadened its customer base, Biotricity increased revenue by 25%, Elutia reported 28% sales growth, and Eton Pharmaceuticals saw a 50% revenue increase.
Journey Medical Corporation's revenue grew by 7% for Q1 2024, and Shield Therapeutics plc reported a 174% increase in Accrufer® prescriptions for Q1 2024.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SWK Holdings Corp.